Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
KU Leuven
Kestrel Therapeutics, Inc.
Canadian Cancer Trials Group
Sun Yat-sen University
Qianfoshan Hospital
Merck Sharp & Dohme LLC
Ohio State University Comprehensive Cancer Center
National Cheng-Kung University Hospital
Alliance for Clinical Trials in Oncology
University of Colorado, Denver
Sun Yat-sen University
NRG Oncology
The First Hospital of Jilin University
Jonsson Comprehensive Cancer Center
Fondazione del Piemonte per l'Oncologia
The First Hospital of Jilin University
GlaxoSmithKline
Chang Gung Memorial Hospital
Dana-Farber Cancer Institute
Rutgers, The State University of New Jersey
Memorial Sloan Kettering Cancer Center
SCRI Development Innovations, LLC
Medtronic - MITG
Medical College of Wisconsin
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Delcath Systems Inc.
Beijing Chao Yang Hospital
Fred Hutchinson Cancer Center
Seventh Medical Center of PLA General Hospital
The Affiliated Hospital of Qingdao University
Zhejiang University
Fondazione del Piemonte per l'Oncologia
Memorial Sloan Kettering Cancer Center
Sun Yat-sen University
Pfizer
The University of Hong Kong
Columbia University
Institute of Oncology Ljubljana
Cedars-Sinai Medical Center
A2 Biotherapeutics Inc.
University of South Florida
Sir Mortimer B. Davis - Jewish General Hospital
University Hospital Tuebingen
Gruppo Oncologico del Nord-Ovest
Washington University School of Medicine
Ohio State University Comprehensive Cancer Center
Washington University School of Medicine
Revolution Medicines, Inc.
H. Lee Moffitt Cancer Center and Research Institute